Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, October 31, 2019
Cycle has signed an agreement with Catalent to develop innovative formulations targeting rare disease patients.
read more
Jason Mitakidis, President and CEO of Cyclica, Peter Pekos, President and CEO of Dalton Pharma Services and Dr. Judd Berman, Co-Founder of Dalton Medicinal Chemistry today announced a collaboration for the joint identification and development of a ...
read more
Wednesday, October 30, 2019
Cyclo Therapeutics has signed an agreement with Worldwide Clinical Trials, a CRO, to conduct a clinical trial to evaluate safety and efficacy in Alzheimer’s Disease.
read more
Monday, December 30, 2019
Cyclo Therapeutics has signed a Master Services Agreement with Worldwide Clinical Trials to serve as CRO for the Company’s clinical programs evaluating Trappsol Cyclo.
read more
Thursday, January 14, 2021
Cyclolab and EpiPharma have signed an agreement to form a joint venture specialty pharmaceutical company to develop and commercialize novel conjugated Cyclodextrin.
read more
Cyrus Biotechnology announced the release of a novel Antibody Structure Prediction Software tool as part of its Cyrus Bench® platform.
read more
Sunday, September 18, 2016
The Cystic Fibrosis Foundation has announced the official opening of a new, one-of-a kind research facility in Lexington, Mass. Operated by Cystic Fibrosis Foundation Therapeutics Inc. (CFFT), an affiliate of the CF Foundation, the lab is designed to...
read more
Monday, September 07, 2020
Cytel has announced the acquisition of Laiya Consulting, a drug development solutions company specializing in Bayesian adaptive trial designs and implementation.
read more
Wednesday, November 06, 2019
Cytel has acquired MTEK Sciences to further expand its advanced real-world analytics (RWA) capabilities.
read more
Cytel announced further expansion in Europe with the addition of an office in Basel, Switzerland.
read more
Cytel Inc. has appointed Albert Kim, MD, PhD, as its first Chief Medical Officer (CMO), driving expansion of the advanced analytics capabilities available to clinicians looking to streamline therapeutic development.
read more
Cytel announced the hire of Thomas Bregenzer as the new Global Head of Biostatistics.
read more
Thursday, September 08, 2022
Cytel expanded its operations into the Asia-Pacific region (APAC). This enables biotech and biopharma companies in APAC to have easier access to Cytel’s established biometrics and advanced statistical solutions.
read more
Wednesday, September 23, 2020
Cytel has widened the geographical scope of the TOGETHER trial, a study to identify early COVID-19 interventions in underserved low- and middle-income country (LMIC) populations.
read more
Cytel announced that it will launch East On Demand™ at the annual Joint Statistical Meetings (JSM) 2019.
read more